Search and Rescue


CLOSE

MENU
Partnership to End Addiction
Monitor Your Patients
Making Use of Your State’s Prescription Drug Monitoring Program

The Prescription Drug Monitoring Program (PDMP) is an online database that houses prescribing and dispensing data for patients per state. The PDMP helps identify when a patient obtains multiple prescriptions from different practitioners—which may indicate that the patient is misusing or is addicted to prescription drugs.8,9

Featuring Daniel P. Alford, MD, MPH, FACP

Find Your State’s PDMP

U.S. PDMP map
US State Prescribing Rates per 100 persons, 201910
>60 prescriptions
50-59.9 prescriptions
40-49.9 prescriptions
<64.1 prescriptions
No Data Available
US State Prescribing Rates per 100 persons, 201910
>60 prescriptions
50-59.9 prescriptions
40-49.9 prescriptions
<64.1 prescriptions
No Data Available

*This campaign is supported by the FDA of the US Department of Health and Human Services (HHS) as part of financial assistance award U18FD004593, with 100% funded by the FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, the FDA/HHS or the US Government.

References
  1. Centers for Disease Control and Prevention. Overdose Death Rates. https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates. Accessed March 21, 2021.
  2. Overdose Detection Mapping Application Program. The consequences of COVID-19 on the overdose epidemic: Overdoses are increasing. https://files.constantcontact.com/a923b952701/dbf0b5a5-f730-4a6f-a786-47097f1eea78.pdf. Accessed March 21, 2021.
  3. American Medical Association. Issue brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic. https://www.ama-assn.org/system/files/2020-12/issue-brief-increases-in-opioid-related-overdose.pdf. Accessed March 21, 2021.
  4. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569-576.
  5. Why guidelines for primary care providers? Centers for Disease Control and Prevention website. https://www.cdc.gov/drugoverdose/pdf/guideline_infographic-a.pdf. Accessed March 21, 2021.
  6. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Results From the 2019 National Survey on Drug Use and Health: Detailed Tables. https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables. Published September 2020. Accessed March 21, 2021.
  7. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1-2):95-100.
  8. Centers for Disease Control and Prevention. Prescription Drug Monitoring Programs (PDMPs). https://www.cdc.gov/drugoverdose/pdmp/providers.html. Accessed April 5, 2021.
  9. Prescription drug monitoring frequently asked questions (FAQ). Brandeis University. Prescription Drug Monitoring Program Training and Technical Assistance Center website. https://www.pdmpassist.org/Policies. Accessed March 21, 2021.
  10. U.S. State Opioid Dispensing Rates, 2019. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. https://www.cdc.gov/drugoverdose/maps/rxstate2019.html. Accessed April 5, 2021.

Copyright © 2021 Partnership to End Addiction Terms of Use Privacy Policy